Lupin receives approval from US FDA for Sildenafil for Oral Suspension
NEW DELHI: Drug maker Lupin has announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US...
NEW DELHI: Drug maker Lupin has announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US...
NEW DELHI: Zydus Lifesciences has received final approval from the US Food and Drug Administration (FDA) to market Adapalene and...